Mirae Asset Global Investments Co., Ltd. Royalty Pharma PLC Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 75,068 shares of RPRX stock, worth $2.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
75,068
Previous 76,034
1.27%
Holding current value
$2.51 Million
Previous $2.15 Million
11.02%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding RPRX
# of Institutions
431Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.32 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$768 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$566 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$472 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...